Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherapeutics and their use in clinical practice.
| From | National Institutes of Health |
|---|---|
| Who can apply | state governments, counties, cities and townships, special districts (water, fire, parks, etc.), school districts, public colleges and universities and 9 more types |
| Eligibility notes | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or… |
| How much | Amount not stated |
| Deadline | Fri, Jan 7, 2028 (441 days left) |
| Category | Health |
| Type | Grant |
| Opportunity # | PAR-25-024 |
| Assistance listing | 93.853, 93.866 |
| Posted | Mon, Oct 28, 2024 |